Clinical Trials · NCT01272219
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 3,731
- Start date
- Jun 2011
- Locations
- 226 sites, 29 countries
- Primary endpoint
- Change From Baseline in Fasting Body Weight